Skip to content

Bionik Laboratories Corp.

company.status.inactive

CIK 1508381fmd_1HJ5C3B3ZZQ5M6JSGGG3HQ1KHEManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Jan 08, 2010 to Mar 31, 2023, 52 periods

Latest annual · FY2023

Millions
Total revenues
2
Gross profit
1
Operating income
(5)
Net income
(5)
Free cash flow
(4)

Latest quarter · Q4 FY2023

Millions
Total revenues
1
Gross profit
0
Operating income
(1)
Net income
(1)
Free cash flow
(1)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2020 to FY2023
-5.7%
Revenue, 5 yearsFY2018 to FY2023
+12.8%
Net income, 5 yearsFY2018 to FY2023
n/m

Bionik Laboratories Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2023FY2022ChangeSource
Revenue$1.8 million$1.3 million+41.7%10-K 2023-06-21 · proof
Gross profit$989,877$953,258+3.8%10-K 2023-06-21 · proof
Operating income-$4.8 million-$10 million10-K 2023-06-21 · proof
Net income-$4.9 million-$10.4 million10-K 2023-06-21 · proof
Cash from operating activities-$3.4 million-$4.1 million10-K 2023-06-21 · proof
Total assets$3.4 million$4.7 million-28.1%10-K 2023-06-21 · proof
Total liabilities$5 million$1.7 million+186.1%10-K 2023-06-21 · proof
Cash and cash equivalents$427,383$2 million-78.5%10-K 2023-06-21 · proof
What was Bionik Laboratories Corp.'s revenue in fiscal 2023?
Bionik Laboratories Corp. reported revenue of $1.8 million for fiscal 2023 (the year ended Mar 31, 2023), against $1.3 million the year before (+41.7%). Source: the 10-K filed with the SEC on Jun 21, 2023. SEC
What was Bionik Laboratories Corp.'s gross profit in fiscal 2023?
Bionik Laboratories Corp. reported gross profit of $989,877 for fiscal 2023 (the year ended Mar 31, 2023), against $953,258 the year before (+3.8%). Source: the 10-K filed with the SEC on Jun 21, 2023. SEC
What was Bionik Laboratories Corp.'s operating income in fiscal 2023?
Bionik Laboratories Corp. reported operating income of -$4.8 million for fiscal 2023 (the year ended Mar 31, 2023), against -$10 million the year before. Source: the 10-K filed with the SEC on Jun 21, 2023. SEC
What was Bionik Laboratories Corp.'s net income in fiscal 2023?
Bionik Laboratories Corp. reported net income of -$4.9 million for fiscal 2023 (the year ended Mar 31, 2023), against -$10.4 million the year before. Source: the 10-K filed with the SEC on Jun 21, 2023. SEC
What was Bionik Laboratories Corp.'s cash from operating activities in fiscal 2023?
Bionik Laboratories Corp. reported cash from operating activities of -$3.4 million for fiscal 2023 (the year ended Mar 31, 2023), against -$4.1 million the year before. Source: the 10-K filed with the SEC on Jun 21, 2023. SEC
What are Bionik Laboratories Corp.'s total assets?
As of Mar 31, 2023, Bionik Laboratories Corp. reported total assets of $3.4 million, against $4.7 million a year earlier (-28.1%). Source: the 10-K filed with the SEC on Jun 21, 2023. SEC
What are Bionik Laboratories Corp.'s total liabilities?
As of Mar 31, 2023, Bionik Laboratories Corp. reported total liabilities of $5 million, against $1.7 million a year earlier (+186.1%). Source: the 10-K filed with the SEC on Jun 21, 2023. SEC
What are Bionik Laboratories Corp.'s cash and cash equivalents?
As of Mar 31, 2023, Bionik Laboratories Corp. reported cash and cash equivalents of $427,383, against $2 million a year earlier (-78.5%). Source: the 10-K filed with the SEC on Jun 21, 2023. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1508381&period_type=annual&limit=5"

Information only, not investment advice.